Buyer for pharmaceutical CMO capsule manufacturer in Europe

Company to buy

• Size: Medium
• Revenue: 5 – 50 million EUR
• Target location: Europe
• CFIE PHB259

Overview of buyer for pharmaceutical CMO capsule manufacturer in Europe

Established in 1991, when a team of seasoned professionals ventured into the pharmaceutical supply market. This marked the inception of a company that has since become a significant player in the industry. Primarily its foundation is built on expertise in distribution, marketing, outsourcing, and pharmaceutical product manufacturing. In addition, the company has embraced innovative management practices and business process optimization. This strategic approach facilitated their penetration into the international market. Remarkably, in less than three decades, they emerged as a model of ambition and ethical conduct, extending their presence to 30 countries.

Profile of buyer for pharmaceutical CMO capsule manufacturer in Europe

Predominately, the company’s growth is attributed to its strategic partnership with leading manufacturers. As a result, this has allowed for a steady expansion of its competencies. By 2011, they had developed the capability to cover nearly the entire spectrum of services within the pharmaceutical sector. Altogether, this comprehensive service offering has positioned them as a versatile and reliable partner in the industry. In particular, their name embodies the values they stand for, such as evolutionary development, versatility, opportunity, loyalty, enthusiasm, and teamwork. These principles guide their operations and corporate culture, driving their commitment to providing high-quality, affordable pharmaceutical products.

Activity and products of buyer for pharmaceutical CMO capsule manufacturer in Europe

Essentially, the company offers a full range of services in the pharmaceutical industry, from drug development to retail sales. Moreover, their centralized management approach has significantly reduced costs, enhancing the price-quality ratio of their products. Notably, their portfolio boasts over 1,200 products, demonstrating their extensive capability in pharmaceutical manufacturing and distribution. In 2023, they further solidified their commitment to innovation and development by commencing the construction of an advanced R&D center. This state-of-the-art facility is equipped with world-class formulation units designed to meet regulatory standards in diverse markets including Europe, CIS, Australia, SEAS, and Latin America.

In total, the R&D center’s formulation development capacity encompasses:

• Oral solids: Including various tablet forms (uncoated, film-coated, sustained release, extended-release, bilayered) and capsules (immediate and controlled release).
• Sterile formulations: Vials (lyophilized and non-lyophilized injections), ampoules, and ophthalmic preparations.
• Liquid formulations: Suspensions, solutions, emulsions, powder for suspensions, and liquid stick packs.
• Semisolid formulations: Creams, ointments, lotions, and suppositories.

Highlights of buyer for pharmaceutical CMO capsule manufacturer in Europe

Over the years, they have developed core values that include respect, team spirit, innovation, responsibility, professionalism, self-realization, efficiency, and trust. Crucially, these values are at the heart of their corporate culture, which prioritizes diversity, mutual respect, and an inclusive environment where employees are encouraged to continually develop.

A testament to their commitment to cutting-edge research and development, the company’s new R&D center will focus on harmonized dossier development for regulatory approval across various markets. This strategic expansion signifies their dedication to advancing pharmaceutical formulations and meeting the evolving needs of the industry.

As it continues to grow, the company is now looking to acquire a pharmaceutical contract manufacturing organization (CMO) specializing in capsule manufacturing in Europe. This acquisition aligns with their ongoing efforts to expand their manufacturing capabilities and enhance their service offerings in the pharmaceutical sector.

More information on this buyer for pharmaceutical CMO capsule manufacturer in Europe

Please get in touch if you are interested in learning more about this buyer for pharmaceutical CMO capsule manufacturer in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.